Skip to main content
Account

Table 1 Mean (±SD) PFU/well of monkeypox virus treated with silver nanoparticles or silver nitrate

From: A Preliminary Assessment of Silver Nanoparticle Inhibition of Monkeypox Virus Plaque Formation

Treatment

Concentration (μg/mL)

100

50

25

12.5

0

Ag-PS-10

10 ± 3.2*

16 ± 7.5*

16 ± 4.7*

19 ± 6.7*

a

Ag-PS-25c

58 ± 7.4

50 ± 3.8

47 ± 5.7

42 ± 5.4

Ag-NP-25

74 ± 11

86 ± 7.8

87 ± 7.9

71 ± 3.1

Ag-NP-55c

72 ± 5.7

67 ± 3.1

51 ± 7.4

41 ± 3.8

Ag-PS-80

71 ± 13

75 ± 6.7

67 ± 7.0

61 ± 7.0

Ag-NP-80

50 ± 16

47 ± 15

40 ± 16

36 ± 15

AgNO3

NDb

34 ± 10*

33 ± 5.2*

29 ± 8.8*

Control

48 ± 9.9

Blank

0

0

0

0

0

  1. aNot applicable
  2. bNot determined due to observed cytotoxicity
  3. cSignificant effect of all test compound concentrations on mean PFU/well (one-way ANOVA;P ≤ 0.05)
  4. * Mean value is significantly lower than control (t-test;P ≤ 0.05)

Navigation